Učitavanje...

LOWERING THE RISK FOR THROMBUS AND STROKE IN ATRIAL FIBRILLATION PATIENTS: Will Dabigatran Replace Warfarin?

The use of oral anticoagulation to reduce stroke risk from thromboembolism has become the cornerstone of management of atrial fibrillation. Dabigatran is a direct thrombin inhibitor, which in contrast to warfarin, does not require regular blood draws for monitoring effect. Randomized controlled stud...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Tan, Alex Y., Rosenberg, Michael A.
Format: Artigo
Jezik:Inglês
Izdano: 2013
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC4170944/
https://ncbi.nlm.nih.gov/pubmed/25253992
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4137/CMRVH.S6415
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!